Literature DB >> 22408752

Carotid artery intima media thickness as a surrogate marker of atherosclerosis in patient with chronic renal failure on hemodialysis.

Jayanta Paul1, Somnath Dasgupta, Mrinal Kanti Ghosh.   

Abstract

BACKGROUND: In patients with chronic renal failure (CRF), carotid artery intima media thickness (CAIMT) is increased when the patients are on hemodialysis. Vascular events caused by atherosclerosis are the major cause of death in patients undergoing hemodialysis. AIMS: This study was done to find out the relationship between carotid artery intima media thickness and hemodialysis in chronic renal failure patients independent of classical risk factors and also the relationship between CAIMT of hemodialyzed patients and nonhemodialyzed CRF patients.
MATERIALS AND METHODS: In this observational study, CAIMT of 78 CRF patients was examined by B-mode ultrasonography. Glomerular filtration rate (GFR) was calculated by using the "Modification of Diet in Renal Disease" formula. CRF patients, who had been on regular hemodialysis treatment (treated thrice weekly) for at least 6 months, were identified as hemodialyzed patients. Data were analyzed by software Statistical package for the social Sciences (SPSS) (17(th) version).
RESULTS: There was significant positive correlation between CAIMT and hemodialysis (P=0.045) independent of traditional risk factors. Hemodialyzed patients had higher mean CAIMT (1136.30±21.21 μm, P<0.001) than mean CAIMT of age and sex matched nondialyzed patients (959.30±23.01 μm).
CONCLUSION: Hemodialysis is an independent risk factor for atherosclerosis in CRF patents. Hemodialyzed patients have significantly higher CAIMT than nondialyzed CRF patients.

Entities:  

Keywords:  Atherosclerosis; Carotid artery intima media thickness; Chronic renal failure; Dialysis; Traditional risk factors of atherosclerosis

Year:  2012        PMID: 22408752      PMCID: PMC3296323          DOI: 10.4103/1947-2714.93379

Source DB:  PubMed          Journal:  N Am J Med Sci        ISSN: 1947-2714


Introduction

In patients with chronic kidney dysfunction, cardiovascular disease (CVD) is twice as common as in the general population.[1] Cardiovascular events are also the leading cause of death in chronic hemodialysis patients.[2] Patients undergoing hemodialysis (HD) have progressive atherosclerosis.[3] Besides the renal disease itself, hemodialysis may also be one of the risk factors for atherosclerosis.[4] The cardiovascular mortality rate is 20–40 times higher for adults on dialysis than for the general population.[56] Carotid artery intima media thickness (CAIMT) was also an independent predictor of Cardiovascular (CV) death in nondiabetic hemodialysis patients.[7] Ultrasound measurements of the intima media thickness (IMT) in the carotid arteries were used as an indicator of carotid atherosclerosis.[8] In several recent studies, ultrasound measurements of IMT in carotid arteries were also used as the indicator of atherosclerosis in dialysis patients. Benedetto et al[9] found that carotid artery IMT represented an independent predictor of cardiovascular death in dialysis patients. In patients on HD, the CAIMT has been found to be a strong predictor of cardiovascular or all-cause mortality.[1011] The aims of our study were to find out (1) the relationship between CAIMT as a surrogate marker of atherosclerosis and hemodialysis independent of traditional risk factors, (2) relationship between CAIMT of hemodialyzed CRF patients and CRF patients without hemodialysis.

Materials and Methods

In this prospective observational study, the study subjects included 78 patients with CRF (GFR <60 ml/min per 1.73 m 2 for 3 months or more with or without kidney damage).[12] Consecutive samples were taken. All subjects underwent a careful interview and clinical, radiological, biochemical examination with an evaluation of patient history based on hospital and outpatients records. In this study, blood pressure, fasting blood sugar, 24 h total urine albumin excretion, hypertension, dyslipidemia, smoking were included as modifiable traditional risk factors. Age and sex were nonmodifiable traditional risk factors. Hypertension was diagnosed when a patient had received medicine for hypertension or had systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg after taking 5 min rest. Fasting blood sugar was measured by a “glucose oxidase-peroxidase” method. Diabetes was diagnosed according to “American Diabetes Association” when a previous or current 12 h fasting glucose level is 7 mmol/l or greater (≥126 mg%). Total cholesterol was estimated by "cholesterol oxidase-peroxidase" method. Patients who used cholesterol lowering medication or had a total serum cholesterol level ≥200 mg/dl were classified as having hypercholesterolemia or dyslipidemia.[13] Twenty four hours total urine albumin excretion is the “gold stander” for measurement of albuminuria,[14] and here it was measured by Esbach's albuninometer. Kidney damage was defined as a microalbuminuria between 17–300 mg/g for men and 25–300 mg/g for women.[15] Serum creatinine was estimated by kinetic alkaline picrate (Jaffe) method. Estimated GFR (eGFR) was calculated using the modification of diet in renal disease (MDRD) formula:[16] eGFR=186.3 × (serum creatinine–1.154) × (age–0.203) × 1.212 (if black) × 0.742 (if female). Venous blood was taken in the morning after an overnight fast for at least 12 hours for biochemical analysis. All biochemical measurements were estimated through Department of Biochemistry, Burdwan Medical College. Smoking history was assessed by participant's self report. Participants were classified as never-smokers if they responded that they had smoked fewer than 100 cigarettes or 5 packs of cigarettes during their lifetime.[17] CRF patients, who had been on regular hemodialysis treatment (treated thrice weekly) for at least 6 months,[18] were identified as hemodialyzed patients in this study. Examination of the carotid arteries was performed with a 7 MHz B-mode ultrasound system. CAIMT defined as a low-level echo gray band that does not project into the arterial lumen, was measured at the diastolic phase as the distance between the leading edge of the first and second echogenic lines of the far walls of the distal segment of the common carotid artery, the carotid bifurcation, and the internal carotid artery on both sides[18] and was measured with a duplex ultrasound system with 7.5 MHz scanning frequency in the B-mode, pulsed Doppler mode and color mode. The B-mode scanning protocol included the scanning of the right and left common carotid arteries (3 cm before the carotid bifurcation), carotid bifurcation, as well as of the internal carotid artery 2 cm distally from the carotid bifurcation.[19] CAIMT measurements were always performed in plaque-free arterial segments.[18] All examinations and measurements were performed by same examiner to exclude examiner bias.

Statistical study

Chi-square test, Independent samples t-test, and Linear multivariate regression analysis were performed for result and analysis. P value less than 0.05 was taken as statistically significant. All these analysis were performed using a commercially available software SPSS (window version 17.0) on personal computer. Data were expressed as means±SE (Standard Error).

Results

Out of 78 CRF patients, 46.15% patients were on hemodialysis and 53.85% were without hemodialysis. 80.56% of hemodialyzed patients were male and 19.44% were female. 61.90% of nondialyzed patients were male and 38.10% were female. Mean age of hemodialyzed patients was 51.47±2.17 years and mean age of nondialyzed patients was 50.47±2.27 years [Table 1]. Independent samples t-test for equality of means found that there was no significant difference of mean age between hemodialyzed and nondialyzed patients (P=0.752) [Table 2]. Chi-square test also showed that there is no significant difference in gender distribution between hemodialyzed and nondialysis CRF patients (P>0.05). So in this study, CAIMT of 36 hemodialyzed patients were compared with age and sex matched 42 nondialyzed CRF patients.
Table 1

Mean CAIMT and age of dialyzed and nondialyzed CRF patients

Table 2

Independent samples t-test for equality of means

Mean CAIMT and age of dialyzed and nondialyzed CRF patients Independent samples t-test for equality of means There was significant positive correlation between CAIMT and hemodialysis independent of traditional risk factors, P=0.045 [Table 3]. Hemodialyzed CRF patients had higher mean CAIMT (1136.30±21.21 μm) than age- and sex-matched CRF patients without hemodialysis (959.30±23.02 μm) [Table 1]. Independent samples t-test for Equality of Means found that there was significant difference of mean CAIMT between hemodialysis and non-dialysis CRF patients (P<0.001) [Table 2].
Table 3

Linear multivariate regression analysis of traditional risk factors correlating with CAIMT

Linear multivariate regression analysis of traditional risk factors correlating with CAIMT In this study, there was also independently positive significant correlation of age (P=0.047), sex (P=0.002), smoking (P=0.047), hypercholesterolemia (P=0.021), hypertension (P=0.003), 24 h total urine protein excretion (P=0.003), fasting blood sugar (P=0.035) with CAIMT. Here GFR was negatively correlated with CAIMT (P=0.001) [Table 3].

Discussion

Life expectancy is reduced in CRF patients comparing with normal population. Death due to cardiovascular disease (CVD) is common among hemodialysis patients. The relative risk of CVD death in this group of patients was high as 10–30 times.[20-22] In this study, higher value of mean carotid artery intima media thickness in CRF patients on hemodialysis was found than in age- and sex-matched CRF patients without dialysis. These results are in accordance with other authors.[2324] Increased carotid artery IMT is considered as a marker of early atherosclerotic changes.[25] The normal intima-medial thickness of common carotid artery as evaluated by B-mode ultrasound imaging was 0.74±0.14 mm[26] and CAIMT at or above 1 mm is associated with atherosclerosis and a significantly increased CVD risk in any age group.[2728] Therefore, in our study, CRF patients on hemodialysis were suffering from atherosclerosis (mean CIAMT=1136.30±21.21 μm) and patients without hemodialysis were also associated with higher CAIMT (mean CAIMT=959.30±23.02 μm) than normal. As per several studies,[29] known traditional risk factors such as age, sex, hypercholesterolemia, hypertension, fasting blood sugar, and smoking were also implicated in inducing atherosclerosis in CRF patients in our study. There are some limitations in this study: (1) premature atherosclerosis, serum homocysteine, lipoprotein (a), obesity, physical activity, atherogenic diet, proinflammatory factors, and prothrombotic factors could not be included due to the limitations of budget and study design, (2) small number of participants.

Conclusion

Hemodialysis is an independent risk factor of atherosclerosis in CRF patients. Measurement of CAIMT has a value to diagnose the atherosclerosis in CRF patients on hemodialysis after traditional risk factors have been taken into consideration. Aggressive control of modifiable traditional risk factors may reduce the progression of atherosclerosis in hemodialysis patients because they are also independent risk factors of atherosclerosis.
  23 in total

1.  Cardiovascular disease and chronic renal disease: a new paradigm.

Authors:  M J Sarnak; A S Levey
Journal:  Am J Kidney Dis       Date:  2000-04       Impact factor: 8.860

2.  Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients.

Authors:  Francesco Antonio Benedetto; Francesca Mallamaci; Giovanni Tripepi; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2001-11       Impact factor: 10.121

Review 3.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

4.  High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia.

Authors:  T Kawagishi; Y Nishizawa; T Konishi; K Kawasaki; M Emoto; T Shoji; T Tabata; T Inoue; H Morii
Journal:  Kidney Int       Date:  1995-09       Impact factor: 10.612

Review 5.  Carotid artery intima-media thickness as an indicator of generalized atherosclerosis.

Authors:  D E Grobbee; M L Bots
Journal:  J Intern Med       Date:  1994-11       Impact factor: 8.989

6.  Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study.

Authors:  T E Craven; J E Ryu; M A Espeland; F R Kahl; W M McKinney; J F Toole; M R McMahan; C J Thompson; G Heiss; J R Crouse
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

7.  Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  G Howard; L E Wagenknecht; G L Burke; A Diez-Roux; G W Evans; P McGovern; F J Nieto; G S Tell
Journal:  JAMA       Date:  1998-01-14       Impact factor: 56.272

8.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

9.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

Authors:  A S Levey; J A Beto; B E Coronado; G Eknoyan; R N Foley; B L Kasiske; M J Klag; L U Mailloux; C L Manske; K B Meyer; P S Parfrey; M A Pfeffer; N K Wenger; P W Wilson; J T Wright
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

10.  Carotid atherosclerosis in chronic renal failure-the central role of increased plaque burden.

Authors:  Yrjö Leskinen; Terho Lehtimäki; Antti Loimaala; Visa Lautamatti; Timo Kallio; Heini Huhtala; Juha P Salenius; Heikki Saha
Journal:  Atherosclerosis       Date:  2003-12       Impact factor: 5.162

View more
  8 in total

1.  Melatonin receptor 1A gene polymorphism rs13140012 and serum melatonin in atherosclerotic versus non-atherosclerotic Egyptian ESRD patients: pilot study.

Authors:  Aliaa Aly El Aghoury; Eman Tayae Elsayed; Noha Mohamed El Kholy; Mohamed Hesham El Nashar; Tarek M Salem
Journal:  Heliyon       Date:  2020-07-11

2.  The impact of athrosclerosis on cognition and disability in multiple sclerosis patients: the ATHUS score.

Authors:  A V Valavanis; E Tsitsipa; S Intzes; E Psoma; T Tegos
Journal:  Hippokratia       Date:  2019 Apr-Jun       Impact factor: 0.471

3.  Carotid Intima Media Thickness as a Reflection of Generalized Atherosclerosis is Related to Body Mass Index in Ischemic Stroke Patients.

Authors:  Amit Shankar Singh; Virendra Atam; Munna Lal Patel; Shyam Chand Chaudhary; Kamal Kumar Sawlani; Liza Das
Journal:  N Am J Med Sci       Date:  2013-03

4.  Chlamydophila pneumoniae infection and cardiovascular disease.

Authors:  Rajnish Joshi; Bidita Khandelwal; Deepti Joshi; Om Prakash Gupta
Journal:  N Am J Med Sci       Date:  2013-03

5.  Risk of Retinal Artery Occlusion in Patients With End-Stage Renal Disease: A Retrospective Large-Scale Cohort Study.

Authors:  Yuh-Shin Chang; Shih-Feng Weng; Chun Chang; Jhi-Joung Wang; Sung-Huei Tseng; Shun-Yao Ko; Shih-Bin Su; Chien-Cheng Huang; Jiu-Yao Wang; Ren-Long Jan
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

6.  Sonography of common carotid arteries' intima: media thickness in the normal adult population in Sudan.

Authors:  Mustafa Z Mahmoud
Journal:  N Am J Med Sci       Date:  2013-02

7.  Association of carotid plaque echogenicity with recurrence of ischemic stroke.

Authors:  Amit Shankar Singh; Virendra Atam; Nirdesh Jain; Besthanahalli Errapa Yathish; Malagouda R Patil; Liza Das
Journal:  N Am J Med Sci       Date:  2013-06

8.  Impact of Malnutrition, Inflammation, and Atherosclerosis on the Outcome in Hemodialysis Patients.

Authors:  B B Kirushnan; B Subba Rao; R Annigeri; S Balasubramanian; R Seshadri; K C Prakash; V Vivek
Journal:  Indian J Nephrol       Date:  2017 Jul-Aug
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.